Advertisement
Abstract

Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner.

M Scott and D J Carr
Journal of Pharmacology and Experimental Therapeutics August 1996, 278 (2) 980-988;

Article Information

vol. 278 no. 2 980-988
PubMed 
8768756
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online August 1, 1996.

Author Information

  1. M Scott and
  2. D J Carr
  1. Department of Microbiology and Immunology, Louisiana State University Neuroscience, New Orleans, USA.

    Statistics from Altmetric.com

    Article usage

    Article usage: January 2000 to January 2023

    AbstractFullPdf
    Jan 2000100
    Feb 2000100
    Sep 2000100
    Feb 2001100
    May 2001200
    Mar 2002100
    Jul 2003100
    Aug 2003301
    Sep 2003300
    Oct 2003300
    Nov 2003300
    Dec 2003100
    Jan 2004300
    Feb 2004500
    Mar 2004200
    Apr 2004500
    May 2004400
    Jun 2004300
    Jul 2004800
    Aug 20041200
    Sep 2004900
    Oct 2004700
    Nov 20041000
    Dec 2004900
    Jan 20051300
    Feb 2005500
    Mar 2005700
    Jul 2005300
    Aug 2005100
    Sep 2005100
    Oct 2005100
    Dec 2005300
    Feb 2006100
    Apr 2006001
    Jun 2006200
    Oct 2006002
    Dec 2006200
    Jan 2007100
    Mar 2007100
    Apr 2007002
    May 2007102
    Jun 2007101
    Aug 2007101
    Oct 2007100
    Nov 2007002
    Mar 2008100
    Apr 2008100
    Jun 2008201
    Jul 2008502
    Aug 2008100
    Sep 2008301
    Oct 2008401
    Nov 2008200
    Dec 2008101
    Jan 2009101
    Feb 2009105
    Mar 2009001
    May 2009200
    Sep 2009300
    Oct 2009502
    Nov 2009200
    Dec 2009400
    Jan 2010002
    Feb 2010300
    Mar 2010501
    Apr 2010500
    May 2010302
    Jun 2010200
    Jul 2010200
    Aug 2010101
    Jan 2011100
    Feb 2011100
    Mar 2011500
    Apr 2011500
    May 2011300
    Jun 2011302
    Jul 2011600
    Aug 2011100
    Sep 2011201
    Oct 2011601
    Nov 2011200
    Dec 2011502
    Jan 2012100
    Feb 2012300
    Mar 2012500
    Apr 2012300
    May 2012401
    Jun 2012300
    Jul 2012300
    Aug 2012200
    Sep 2012100
    Oct 2012400
    Nov 2012302
    Dec 2012203
    Feb 2013300
    Mar 2013200
    Apr 2013400
    May 2013200
    Jun 2013504
    Oct 2013101
    Nov 2013100
    Dec 2013100
    Jan 2014100
    Feb 2014202
    Mar 2014001
    Apr 2014503
    May 2014200
    Jun 2014100
    Jul 2014201
    Aug 2014100
    Sep 2014101
    Nov 2014201
    Dec 2014001
    Feb 2015100
    Mar 2015100
    Apr 2015001
    Jun 2015100
    Jul 2015100
    Aug 2015302
    Sep 2015100
    Oct 2015400
    Nov 2015100
    Dec 2015400
    Jan 2016500
    Mar 2016200
    Apr 2016200
    Jun 2016200
    Sep 2016412
    Oct 2016301
    Nov 20161400
    Dec 2016200
    Jan 2017200
    Feb 2017400
    Mar 2017400
    Apr 2017100
    May 20171000
    Jun 2017600
    Jul 2017400
    Aug 2017400
    Sep 2017300
    Oct 2017900
    Nov 2017300
    Dec 2017700
    Jan 2018400
    Feb 2018800
    Mar 2018300
    Apr 2018200
    May 2018700
    Jun 2018800
    Jul 2018300
    Aug 2018400
    Sep 2018500
    Oct 2018400
    Nov 2018600
    Dec 2018300
    Feb 2019600
    Apr 2019400
    May 2019200
    Jun 2019002
    Aug 2019200
    Sep 2019100
    Oct 2019500
    Nov 2019700
    Dec 2019200
    Jan 2020100
    Feb 2020400
    Apr 2020100
    May 2020200
    Jun 2020100
    Jul 2020100
    Aug 2020200
    Sep 2020500
    Oct 2020100
    Nov 2020500
    Dec 2020200
    Jan 2021600
    Feb 2021600
    Mar 20211000
    Apr 2021800
    May 20211900
    Jun 2021100
    Jul 2021600
    Aug 2021500
    Sep 2021500
    Oct 2021900
    Nov 20211700
    Dec 2021502
    Jan 2022700
    Feb 2022500
    Mar 2022300
    Apr 2022800
    May 2022200
    Jun 20221300
    Jul 20221100
    Aug 2022700
    Sep 2022900
    Oct 2022300
    Nov 2022400
    Dec 2022200
    Jan 2023800

    Back to top

    In this issue

    Download PDF
    Article Alerts
    Email Article
    Citation Tools

    Abstract

    Morphine suppresses the alloantigen-driven CTL response in a dose-dependent and naltrexone reversible manner.

    M Scott and D J Carr
    Journal of Pharmacology and Experimental Therapeutics August 1, 1996, 278 (2) 980-988;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo

    Jump to section

    Related Articles

    Cited By...

    Similar Articles

    Advertisement